Long-Term Immunity and Antibody Response: Challenges for Developing Efficient COVID-19 Vaccines

Long-Term Immunity and Antibody Response: Challenges for Developing Efficient COVID-19 Vaccines

Questions and concerns regarding the efficacy and immunogenicity of coronavirus disease 2019 (COVID-19) vaccines have plagued scientists since the BNT162b2 mRNA vaccine was introduced in late 2020. As a result, decisions about vaccine boosters based on breakthrough infection rates and the decline of...

Full description

Bibliographic Details
Main Authors: Mohammad Reza Sepand, Banafsheh Bigdelou, Jim Q. Ho, Mohammad Sharaf, Alexis J. Lannigan, Ian M. Sullivan, Alecsander P. da Silva, Leland O. Barrett, Scott McGoldrick, Yuvraj Lnu, Shannon E. Lynch, Jared M. Boisclair, Dakarai D. Barnard-Pratt, Steven Zanganeh
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Antibodies
Subjects:
SARS-CoV-2
immunogenicity
vaccine
COVID-19
antibodies
Online Access:https://www.mdpi.com/2073-4468/11/2/35

Internet

https://www.mdpi.com/2073-4468/11/2/35

Similar Items